| Paul K Yoo, DO | |
|
11850 Blackfoot St Nw Ste 405, Coon Rapids, MN 55433-2773 | |
| (763) 236-0888 | |
| Not Available |
| Full Name | Paul K Yoo |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 10 Years |
| Location | 11850 Blackfoot St Nw Ste 405, Coon Rapids, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912325010 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital | Coon rapids, MN | Hospital |
| Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allina Health System | 4587573613 | 3071 |
News Archive
A recent study, "Perceived Benefit of Complementary and Alternative Medicine for Back Pain" (Journal of the American Board of Family Medicine, May - June 2010, Vol. 23 No.3), found the majority of respondents receiving CAM for back pain reported great benefit from the various treatments.
For researchers with The Ohio State University College of Veterinary Medicine, the work to identify new flu strains and increase the effectiveness of the flu vaccine begins in an unlikely place – pig barns at state and county fairs nationwide.
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, has announced positive results from a planned interim analysis of data collected six months after dosing from its ongoing Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. At its best performing dose of 60 µg per protein / 75 µg of Matrix-M2TM adjuvant, GEN-003 demonstrated a statistically significant 58 percent reduction from baseline in the viral shedding rate (p < 0.0001), the primary endpoint of the study.
Complete resection with segmentectomy is as effective as lobectomy for patients with solid-dominant clinical stage IA lung adenocarcinoma, Japanese study findings suggest.
› Verified 9 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
A recent study, "Perceived Benefit of Complementary and Alternative Medicine for Back Pain" (Journal of the American Board of Family Medicine, May - June 2010, Vol. 23 No.3), found the majority of respondents receiving CAM for back pain reported great benefit from the various treatments.
For researchers with The Ohio State University College of Veterinary Medicine, the work to identify new flu strains and increase the effectiveness of the flu vaccine begins in an unlikely place – pig barns at state and county fairs nationwide.
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, has announced positive results from a planned interim analysis of data collected six months after dosing from its ongoing Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. At its best performing dose of 60 µg per protein / 75 µg of Matrix-M2TM adjuvant, GEN-003 demonstrated a statistically significant 58 percent reduction from baseline in the viral shedding rate (p < 0.0001), the primary endpoint of the study.
Complete resection with segmentectomy is as effective as lobectomy for patients with solid-dominant clinical stage IA lung adenocarcinoma, Japanese study findings suggest.
› Verified 9 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457657249 PECOS PAC ID: 4587573613 Enrollment ID: O20221213001713 |
News Archive
A recent study, "Perceived Benefit of Complementary and Alternative Medicine for Back Pain" (Journal of the American Board of Family Medicine, May - June 2010, Vol. 23 No.3), found the majority of respondents receiving CAM for back pain reported great benefit from the various treatments.
For researchers with The Ohio State University College of Veterinary Medicine, the work to identify new flu strains and increase the effectiveness of the flu vaccine begins in an unlikely place – pig barns at state and county fairs nationwide.
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, has announced positive results from a planned interim analysis of data collected six months after dosing from its ongoing Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. At its best performing dose of 60 µg per protein / 75 µg of Matrix-M2TM adjuvant, GEN-003 demonstrated a statistically significant 58 percent reduction from baseline in the viral shedding rate (p < 0.0001), the primary endpoint of the study.
Complete resection with segmentectomy is as effective as lobectomy for patients with solid-dominant clinical stage IA lung adenocarcinoma, Japanese study findings suggest.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul K Yoo, DO 2925 Chicago Ave, Minneapolis, MN 55407-1321 Ph: (612) 262-9000 | Paul K Yoo, DO 11850 Blackfoot St Nw Ste 405, Coon Rapids, MN 55433-2773 Ph: (763) 236-0888 |
News Archive
A recent study, "Perceived Benefit of Complementary and Alternative Medicine for Back Pain" (Journal of the American Board of Family Medicine, May - June 2010, Vol. 23 No.3), found the majority of respondents receiving CAM for back pain reported great benefit from the various treatments.
For researchers with The Ohio State University College of Veterinary Medicine, the work to identify new flu strains and increase the effectiveness of the flu vaccine begins in an unlikely place – pig barns at state and county fairs nationwide.
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, has announced positive results from a planned interim analysis of data collected six months after dosing from its ongoing Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. At its best performing dose of 60 µg per protein / 75 µg of Matrix-M2TM adjuvant, GEN-003 demonstrated a statistically significant 58 percent reduction from baseline in the viral shedding rate (p < 0.0001), the primary endpoint of the study.
Complete resection with segmentectomy is as effective as lobectomy for patients with solid-dominant clinical stage IA lung adenocarcinoma, Japanese study findings suggest.
› Verified 9 days ago
Melissa J. Merriman-flory, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 9055 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 763-780-9155 | |
Darci J. Olson, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 9055 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 763-236-1040 | |
Dr. Sarah Elizabeth Elert, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 320 Coon Rapids Blvd Nw Ste 100, Coon Rapids, MN 55433 Phone: 763-201-8191 | |
Sarah E Sievert, PT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3111 124th Ave Nw, Suite 200, Coon Rapids, MN 55433 Phone: 763-427-7300 Fax: 763-427-2802 | |
Paul John Overshiner, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 9055 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 763-780-9155 | |
Danielle Therese Schlomann, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 9055 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 763-780-9155 | |
Dr. Nancy Ann Henry-socha, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 11850 Blackfoot St Nw Ste 4, Coon Rapids, MN 55433 Phone: 763-236-0888 |